WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SF 2670

Legislative bill overview

SF 2670 requires phototherapy light devices to be priced and sold individually rather than only in bundled packages. The bill mandates that manufacturers and retailers offer consumers the option to purchase single phototherapy lights at transparent unit prices. This applies to medical-grade devices used for treating conditions like seasonal affective disorder (SAD), jaundice, and certain skin conditions.

Why is this important

Phototherapy devices can be expensive, and bundle-only pricing practices may force consumers to pay for unnecessary additional units or accessories. Individual pricing transparency allows patients and healthcare providers to make cost-effective purchasing decisions and could reduce out-of-pocket expenses for those with medical need. This particularly affects individuals with limited incomes who need therapeutic light treatment but cannot afford bundled packages.

Potential points of contention

  • Business impact: Manufacturers and retailers may argue that bundling allows them to offer discounts and that unbundling increases per-unit costs, potentially raising prices for consumers overall
  • Scope definition: Unclear whether the bill applies only to medical devices, consumer wellness products, or both; could create regulatory ambiguity about which products are covered
  • Market feasibility: Small retailers may face operational challenges in stocking and managing inventory of individual units versus pre-packaged bundles, potentially reducing product availability in some areas

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.